Search Results

You searched for : neuroblastoma  

Researchers found new Cancer Drug in memory of a 9 year old girl

In a groundbreaking medical breakthrough, a new cancer drug has emerged, inspired by the courage and resilience of a 9-year-old girl. This promising ...
Aug 03

International Childhood Cancer Day 2023 – Awareness, accessible and affordable healthcare

Every 3 minutes, a child dies of cancer. Think about it. This International Childhood Cancer Day, let’s stand united to make childhood cancer a ...
Feb 15

Childhood Cancer Awareness Month 2022 – Together accelerating the cure of cancer in children

Children are blessings from god. We all have unconditional love for our children. And what if, one day you come to know that the child ...
Sep 17

Dr. Priti Mehta a pediatric hematologist oncologist explains the facts about preimplantation genetic diagnosis

...
Jan 21

FDA Approves Y-mAbs’ DANYELZA® (naxitamab-gqgk) for the Treatment of Neuroblastoma

Y-mAbs Therapeutics today announced that the U.S. Food and Drug Administration (“FDA”) has approved DANYELZA (naxitamab-gqgk) for the Treatment of Neuroblastoma....
Nov 26

Y-mAbs’ Nivatrotamab granted Orphan Drug Designation and Rare Pediatric Disease designation by FDA

Researchers at Memorial Sloan Kettering Cancer Center developed nivatrotamab, which is exclusively licensed by MSK to Y-mAbs...
Oct 09

Council for Healthcare and Pharma Emphasizes Need to Strengthen System for Treatment of Paediatric Cancers

Headquartered in New Delhi, India, CHP focuses on Africa, Brazil, China, Germany, India, Japan, UK and the USA. Its important areas of work are in ...
Feb 17

Neuroblastoma drug goes through successful drug trials

Aptorum Group Limited , a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces positive data and development in ...
Feb 12

Aptorum Group Announces the Development of Microbiome Drug Candidate Targeting Obesity and Repurposed Drug Candidates Targeting Neuroblastoma

Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces the ...
Sep 12

9 Matching result(s) found!

-Advertisements-




Trending Now

Cipla Eyes Eli Lilly Partnership to Tap Growing Demand for Obesity Drugs in IndiaMay 13, 2024
Setback for Organ Transplantion: First Human to Receive Pig Kidney DiesMay 13, 2024
Why AstraZeneca is Withdrawing the Covid-19 Vaccine Globally: Explained May 13, 2024
Achieving Healthier Lifestyles: Understanding India's New Dietary GuidelinesMay 11, 2024
The Link Between Childhood Sleep and Adult Psychosis: A Critical AnalysisMay 11, 2024
Uncovering Immunization Gaps: Insights into Measles Vaccination Challenges in IndiaMay 11, 2024
Unlocking New Horizons: Gene Therapies for Hearing Loss and BlindnessMay 10, 2024
Kerala Health Alert: West Nile Fever Cases Confirmed in Thrissur, Malappuram, and KozhikodeMay 10, 2024
Managing Health in the Heat: Demand for Medications Surges in IndiaMay 10, 2024
Sudhamukti Ayurvedic Medicine by OJSP: A New Era in Diabetes ManagementMay 10, 2024
The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
Reducing Stigma, One Story at a Time: Media's Role in Mental HealthMay 07, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024